Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-β

Journal of Clinical Investigation

Volumn 117, Issue 3, 2007, Pages 784-793

  Yuk, Yin Cheung ^a,b   So, Youn Kim ^a   Wai, Han Yiu ^a   Pan, Chi Jiunn ^a   Jun, Hyun Sik ^a   Ruef, Robert A ^a   Lee, Eric J ^a   Westphal, Heiner ^a   Mansfield, Brian C ^a,c   Chou, Janice Y ^a,d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Correlogic Systems Inc ^*  (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BONE MARROW; CALCIUM TRANSPORT; CELL ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGENOLYSIS; HOMEOSTASIS; HYDROLYSIS; LEUKOCYTE DISORDER; MOUSE; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL DYSFUNCTION; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BACTERIAL INFECTIONS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE-6-PHOSPHATASE; GLUCOSE-6-PHOSPHATE; HEMATOPOIESIS; HOMEOSTASIS; MICE; NEUTROPENIA; NEUTROPHILS; PERITONITIS; PROTEIN SUBUNITS;

EID: 33847420515     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30443     Document Type: Article

References (50)

1. Chou, J.Y., Matern, D., Mansfield, B.C., and Chen, Y.T. 2002. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2:121-143.
2. Chou, J.Y., and Mansfield, B.C. 2003. Glucose-6-phosphate transporter: the key to glycogen storage disease type Ib. In Membrane transporter diseases. S. Broer and C.A. Wagner, editors. Springer. New York, New York, USA. 191-205.
3. Beaudet, A.L., Anderson, D.C., Michels, V.V., Arion, W.J., and Lange, A.J. 1980. Neutropenia and impaired neutrophil migration in type 1B glycogen storage disease. J. Pediatr. 97:906-910.
4. Gitzelmann, R., and Bosshard, N.U. 1993. Defective neutrophil and monocyte functions in glycogen storage disease type 1b: a literature review. Eur. J. Pediatr. 152(Suppl.):S33-S38.
5. Rothbaum, R., et al. 2002. Shwachman-Diamond syndrome: report from an international conference. J. Pediatr. 141:266-270.
6. Badolato, R., Fontana, S., Notarangelo, L.D., and Savoldi, G. 2004. Congenital neutropenia: advances in diagnosis and treatment. Curr. Opin. Allergy Clin. Immunol. 4:513-521.
7. Berliner, N., Horwitz, M., and Loughran, T.P., Jr. 2004. Congenital and acquired neutropenia. Hematology Am. Soc. Hematol. Educ. Program. 63-79.
8. Zeidler, C. 2005. Congenital neutropenias. Hematology. 10 (Suppl. 1):306-311.
9. Pan, C.J., Lei, K.J., Annabi, B., Hemrika, W., and Chou, J.Y. 1998. Transmembrane topology of glucose-6-phosphatase. J. Biol. Chem. 273:6144-6148.
10. Pan, C.J., Lin, B., and Chou, J.Y. 1999. Transmembrane topology of human glucose-6-phosphate transporter. J. Biol. Chem. 274:13865-13869.
11. Lei, K.J., et al. 1996. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type 1a mouse. Nat. Genet. 13:203-209.
12. Hiraiwa, H., Pan, C.-J., Lin, B., Moses, S.W., and Chou, J.Y. 1999. Inactivation of the glucose-6-phosphate transporter causes glycogen storage disease type 1b. J. Biol. Chem. 274:5532-5536.
13. Nordlie, R.C., and Sukalski, K.A. 1985. Multifunctional glucose-6-phosphatase: a critical review. In The enzymes of biological membranes. 2nd Edition. A.N. Martonosi, editor. Springer. New York, New York, USA. 349-398.
14. Pan, C.J., Kei, K.J., Chen, H., Ward, J.M., and Chou, J.Y. 1998. Ontogeny of the murine glucose-6-phosphatase system. Arch. Biochem. Biophys. 358:17-24.
15. Lin, B., Annabi, B., Hiraiwa, H., Pan, C.J., and Chou, J.Y. 1998. Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents. J. Biol. Chem. 273:31656-31670.
16. Guionie, O., Clottes, E., Stafford, K., and Burchell, A. 2003. Identification and characterization of a new human glucose-6-phosphatase isoform. FEBS Lett. 551:159-164.
17. Shieh, J.J., Pan, C.J., Mansfield, B.C., and Chou, J.Y. 2003. Glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J. Biol. Chem. 278:47098-47103.
18. Ghosh, A., Shieh, J.J., Pan, C.J., and Chou, J.Y. 2004. Histidine-167 is the phosphate acceptor in glucose-6-phosphatase-β forming a phosphohistidine-enzyme intermediate during catalysis. J. Biol. Chem. 279:12479-12483.
19. Ghosh, A., et al. 2002. The catalytic center of glucose-6-phosphatase: His176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis. J. Biol. Chem. 277:32837-32842.
20. Kuznetsov, G., and Nigam, S.K. 1998. Folding of secretory and membrane proteins. N. Engl. J. Med. 339:1688-1695.
21. Lee, A.S. 2001. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci. 26:504-510.
22. Kleizen, B., and Braakman, I. 2004. Protein folding and quality control in the endoplasmic reticulum. Curr. Opin. Cell Biol. 16:343-349.
23. Zhang, K., and Kaufman, R.J. 2006. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology. 66(Suppl. 1):S102-S109.
24. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65:1153-1163.
25. Sieff, C.A., Nathan, D.G., and Clark, S.C. 1998. The anatomy and physiology of hematopoiesis. In Hematology of infancy and childhood. Volume 1. 5th edition. D.G. Nathon and S.H. Orkin, editors. W.B. Saunders. Philadelphia, Pennsylvania, USA. 161-236.
26. Chen, L.Y., et al. 2003. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum. Mol. Genet. 12:2547-2558.
27. Borregaard, N., Sehested, M., Nielsen, B.S., Sengelov, H., and Kjeldsen, L. 1995. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 85:812-817.
28. Faurschou, M., and Borregaard, N. 2003. Neutrophil granules and secretary vesicles in inflammation. Microbes Infect. 5:1317-1327.
29. Hestdal, K.K., et al. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:22-28.
30. Fleming, T.J., Fleming, M.L., and Malek, T.R. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151:2399-2408.
31. Stevens, F.J., and Argon, Y. 1999. Protein folding in the ER. Semin. Cell Dev. Biol. 10:443-454.
32. Xu, C., Bailly-Maitre, B., and Reed, J.C. 2005. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115:2656-2664. doi:10.1172/JCI26373.
33. Schroder, M., and Kaufman, R.J. 2005. The mammalian unfolded protein response. Annu. Rev. Biochem. 74:739-789.
34. Vance, J.E., and Steenbergen, R. 2005. Metabolism and functions of phosphatidylserine. Prog. Lipid Res. 44:207-234.
35. Lavrik, I.N., Golks, A., and Krammer, P.H. 2005. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115:2665-2672. doi:10.1172/JCI26252.
36. Siegel, R.M. 2006. Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 6:308-317.
37. Daleke, D.L. 2003. Regulation of transbilayer plasma membrane phospholipid asymmetry. J. Lipid Res. 44:233-242.
38. Blankenberg, F.G. 2004. Recent advances in the imaging of programmed cell death. Curr. Pharm. Des. 10:1457-1467.
39. Kim, S.Y., et al. 2006. Bone-marrow derived cells require a functional glucose-6-phosphate transporter for normal myeloid functions. J. Biol. Chem. 281:28794-28801.
40. Silva, A.J., et al. 1997. Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on Genetic Background in Mice. Neuron. 19:755-759.
41. Wolfer, D.P., Crusio, W.E., and Lipp, H.P. 2002. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci. 25:336-340.
42. Liu, B., Koo, G.C., Yap, E.H., Chua, K.L., and Gan, Y.H. 2001. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect. Immun. 70:504-511.
43. Matsutani, T., Anantha-Samy, T.S., Kang, S.C., Bland, K.I., and Chaudry, I.H. 2005. Mouse genetic background influences severity of immune responses following trauma-hemorrhage. Cytokine. 30:168-176.
44. Kuijpers, T.W., et al. 2003. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood. 101:5021-5024.
45. Hewitt, K.N., Walker, E.A., and Stewart, P.M. 2005. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11beta-hydroxysteroid dehydrogenase type 1 activity. Endocrinology. 146:2539-2543.
46. Lavery, G.G., et al. 2006. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J. Biol. Chem. 281:6546-6551.
47. Tomlinson, J.W., et al. 2004. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25:831-866.
48. Shieh, J.J., Pan, C.J., Mansfield, B.C., and Chou, J.Y. 2004. A potential new role for muscle in blood glucose homeostasis. J. Biol. Chem. 279:26215-26219.
49. Lin, H.Y., et al. 1993. The 170-kDa glucose-regulated stress protein is an endoplasmic reticulum protein that binds immunoglobulin. Mol. Biol. Cell. 4:1109-1119.
50. Gao, J.L., Lee, E.J., and Murphy, P.M. 1999. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189:657-662.